CF is an inherited disorder that severely damages the lungs, digestive system and other organs. CF affects the cells that produce mucus, sweat and digestive juices, causing the fluids to become viscous and sticky, as opposed to lubricating. This causes the secretions to block tubes, ducts and passages—especially in the lungs and pancreas.
Although CF is progressive and needs daily care, people with the condition are usually able to attend school and work. Advances in screening, treatment and nutritional management over the last few decades have contributed to improvements in clinical outcomes, quality of life, and life expectancy.
Since our first solution offerings with Peptamen, we have continued engaging in innovation to develop new generation of formulas with an exclusively licensed pre-digested fat component specifically designed for pancreatic insufficient patients.